DexCom Announces 4-for-1 Stock Split. Here's What Investors Need to Know.
DexCom (NASDAQ: DXCM) has revolutionized the lives of people suffering from diabetes. The company introduced the first real-time continuous glucose monitoring (CGM) system back in 2006, raising the standard of care for a generation of patients.
DexCom's robust business performance is reflected in its surging stock price. Over the past year, shares have climbed by roughly 38%. That's impressive in its own right, but zooming out highlights even stronger growth: shares are up 482% over the past five years and have gained a mind-boggling 4,550% over the course of the past decade.
On Friday, DexCom announced plans to split its shares for the first time in company history. The announcement came on the heels of 20-for-1 stock split announcements from tech giants Alphabet and Amazon. The news is causing some investors to take a fresh look at the medical device maker. Let's recap just how a stock split works and what it means for existing and potential DexCom investors.
Source Fool.com
